Clinical Trials with VMO for Melanoma

This publication has 22 references indexed in Scilit:

• Clonal expansion of T cells following in vitro stimulation with autologous melanoma cells and interleukin-2 studied by molecular analysis of a T cell receptor
  Immunology Letters, 1991
• T‐Cell Clones that react against Autologous Human Tumors
  Immunological Reviews, 1990
• in vivo effects of combination treatment with recombinant interferon‐gamma and ‐alpha in metastatic melanoma
  International Journal of Cancer, 1989
• HUMAN MONOCLONAL ANTIBODY TO GANGLIOSIDE GM2 FOR MELANOMA TREATMENT
  The Lancet, 1989
• Active specific immunotherapy in malignant melanoma
  Seminars in Surgical Oncology, 1989
• The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2
  Annals of Surgery, 1988
• A Multivariate Analysis of Prognostic Factors for Melanoma Patients with Lesions > 3.65 mm in Thickness The Importance of Revealing Alternative Cox Models*
  Annals of Surgery, 1982
• Immunotherapy with viral oncolysates for sarcoma
  Published by American Medical Association (AMA) ,1977
• IMMUNOTHERAPY OF OSTEOSARCOMA PATIENTS WITH VIRUS‐MODIFIED TUMOR CELLS*
  Annals of the New York Academy of Sciences, 1976
• Further Investigations on the Mode of Entry of Vaccinia Virus into Cells
  Journal of General Virology, 1976